Literature DB >> 33859805

Synthesis of C6-Substituted Purine Nucleoside Analogues via Late-Stage Photoredox/Nickel Dual Catalytic Cross-Coupling.

James J Perkins1, Valerie W Shurtleff1, Alayna M Johnson1, Abdellatif El Marrouni1.   

Abstract

Nucleoside analogues have been and continue to be extremely important compounds in drug discovery. Despite the significant effort dedicated to their synthesis, medicinal chemistry campaigns around these structures are often hampered by synthetic challenges. We describe a strategy for the functionalization of purine nucleosides via photoredox and nickel-catalyzed sp2-sp3 cross-coupling. The conditions described herein allow for coupling of unprotected nucleosides with readily available alkyl bromides, providing opportunities for their application to parallel medicinal chemistry.
© 2021 American Chemical Society.

Entities:  

Year:  2021        PMID: 33859805      PMCID: PMC8040254          DOI: 10.1021/acsmedchemlett.0c00673

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  40 in total

1.  Direct method for carbon-carbon bond formation: the functional group tolerant cobalt-catalyzed alkylation of aryl halides.

Authors:  Muriel Amatore; Corinne Gosmini
Journal:  Chemistry       Date:  2010-05-25       Impact factor: 5.236

Review 2.  The many faces of the adamantyl group in drug design.

Authors:  Joe Liu; Daniel Obando; Vivian Liao; Tulip Lifa; Rachel Codd
Journal:  Eur J Med Chem       Date:  2011-02-03       Impact factor: 6.514

3.  Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents.

Authors:  Young Ah Kim; Ashoke Sharon; Chung K Chu; Reem H Rais; Omar N Al Safarjalani; Fardos N M Naguib; Mahmoud H el Kouni
Journal:  Biochem Pharmacol       Date:  2007-01-21       Impact factor: 5.858

4.  Modular, Step-Efficient Palladium-Catalyzed Cross-Coupling Strategy To Access C6-Heteroaryl 2-Aminopurine Ribonucleosides.

Authors:  Helena S Buchanan; Steven M Pauff; Tilemachos D Kosmidis; Andrea Taladriz-Sender; Olivia I Rutherford; Marine Z C Hatit; Sabine Fenner; Allan J B Watson; Glenn A Burley
Journal:  Org Lett       Date:  2017-07-06       Impact factor: 6.005

5.  Nickel-catalyzed reductive coupling of aryl halides with secondary alkyl bromides and allylic acetate.

Authors:  Shulin Wang; Qun Qian; Hegui Gong
Journal:  Org Lett       Date:  2012-06-14       Impact factor: 6.005

6.  6-(Hetero)Arylpurine nucleotides as inhibitors of the oncogenic target DNPH1: synthesis, structural studies and cytotoxic activities.

Authors:  Claire Amiable; Julie Paoletti; Ahmed Haouz; André Padilla; Gilles Labesse; Pierre-Alexandre Kaminski; Sylvie Pochet
Journal:  Eur J Med Chem       Date:  2014-08-01       Impact factor: 6.514

Review 7.  Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases.

Authors:  Lars Petter Jordheim; David Durantel; Fabien Zoulim; Charles Dumontet
Journal:  Nat Rev Drug Discov       Date:  2013-06       Impact factor: 84.694

Review 8.  Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.

Authors:  G Rodriguez
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

9.  Replacing conventional carbon nucleophiles with electrophiles: nickel-catalyzed reductive alkylation of aryl bromides and chlorides.

Authors:  Daniel A Everson; Brittany A Jones; Daniel J Weix
Journal:  J Am Chem Soc       Date:  2012-03-30       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.